- Trials with a EudraCT protocol (1)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
1 result(s) found for: 2020-002435-29.
Displaying page 1 of 1.
EudraCT Number: 2020-002435-29 | Sponsor Protocol Number: CR6086-1-04 | Start Date*: 2021-09-28 | |||||||||||
Sponsor Name:ROTTAPHARM BIOTECH S.R.L. | |||||||||||||
Full Title: An open-label, single-arm, phase Ib/IIa trial to evaluate the safety and efficacy of the EP4 receptor antagonist CR6086 in combination with the PD-1 inhibitor balstilimab (AGEN2034), in patients wi... | |||||||||||||
Medical condition: Pretreated mismatch-repair-proficient and microsatellite stable metastatic colorectal cancer (pMMR–MSS metastatic CRC). | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
